https://www.ace-hta.gov.sg/ 2026-03-31T08:25:38.258Z https://www.ace-hta.gov.sg/about-us/ 2025-09-04T08:13:18.298Z https://www.ace-hta.gov.sg/about-us/committees-we-serve/ 2025-09-09T08:47:23.615Z https://www.ace-hta.gov.sg/about-us/organisational-structure/ 2025-11-03T01:08:52.503Z https://www.ace-hta.gov.sg/about-us/our-expert-panels/ 2025-12-01T03:32:10.833Z https://www.ace-hta.gov.sg/about-us/our-impact/ 2025-07-31T03:15:04.676Z https://www.ace-hta.gov.sg/about-us/who-we-are/ 2025-10-27T07:22:49.737Z https://www.ace-hta.gov.sg/about-us/working-with-us/ 2026-03-17T02:58:45.679Z https://www.ace-hta.gov.sg/contact-us/ 2025-03-20T11:31:07.567Z https://www.ace-hta.gov.sg/healthcare-professionals/ 2025-10-15T17:31:39.595Z https://www.ace-hta.gov.sg/healthcare-professionals/ace-cues-overview/ 2025-03-25T08:11:47.158Z https://www.ace-hta.gov.sg/healthcare-professionals/ace-cues/ 2026-04-02T07:18:49.612Z https://www.ace-hta.gov.sg/healthcare-professionals/ace-cues/asthma-management/ 2025-09-09T08:38:33.978Z https://www.ace-hta.gov.sg/healthcare-professionals/ace-cues/inhaler-technique-videos/ 2025-04-24T02:14:35.999Z https://www.ace-hta.gov.sg/healthcare-professionals/ace-horizon-scanning/ 2025-08-28T13:39:15.369Z https://www.ace-hta.gov.sg/healthcare-professionals/ace-horizon-scanning/3d-printing-and-its-clinical-applications/ 2025-08-28T13:39:15.369Z https://www.ace-hta.gov.sg/healthcare-professionals/ace-horizon-scanning/ace-innovation-trends-report/ 2025-12-08T08:25:20.211Z https://www.ace-hta.gov.sg/healthcare-professionals/ace-horizon-scanning/acqmap-for-patients-with-cardiac-arrhythmia/ 2025-08-28T13:39:15.369Z https://www.ace-hta.gov.sg/healthcare-professionals/ace-horizon-scanning/artificial-intelligence-and-its-clinical-applications/ 2025-08-28T13:39:15.369Z https://www.ace-hta.gov.sg/healthcare-professionals/ace-horizon-scanning/biomarker-based-brain-trauma-assessment-tests/ 2025-11-20T08:16:42.480Z https://www.ace-hta.gov.sg/healthcare-professionals/ace-horizon-scanning/canvas-dx-to-aid-the-diagnosis-of-autism-spectrum-disorder/ 2025-08-28T13:39:15.369Z https://www.ace-hta.gov.sg/healthcare-professionals/ace-horizon-scanning/caption-guidance-to-guide-image-acquisition-in-point-of-care-echocardiography-for-patients-with-cardiovascular-disease/ 2025-08-28T13:39:15.369Z https://www.ace-hta.gov.sg/healthcare-professionals/ace-horizon-scanning/cavaclear-for-patients-with-difficult-inferior-vena-cava-filters-(ivcfs)-retrieval-who-have-failed-a-previous-retrieval-method/ 2025-08-28T13:39:15.369Z https://www.ace-hta.gov.sg/healthcare-professionals/ace-horizon-scanning/cooral-system-for-the-prevention-of-oral-mucositis/ 2025-08-28T13:39:15.369Z https://www.ace-hta.gov.sg/healthcare-professionals/ace-horizon-scanning/cytosponge-for-the-detection-of-patients-with-barrett-oesophagus/ 2025-08-28T13:39:15.369Z https://www.ace-hta.gov.sg/healthcare-professionals/ace-horizon-scanning/echogo-heart-failure-to-aid-in-the-diagnosis-of-heart-failure-with-preserved-ejection-fraction/ 2025-11-20T08:16:19.852Z https://www.ace-hta.gov.sg/healthcare-professionals/ace-horizon-scanning/edison-histotripsy-system/ 2025-11-20T08:00:41.339Z https://www.ace-hta.gov.sg/healthcare-professionals/ace-horizon-scanning/feops-heartguide-for-procedure-planning-in-patients-needing-transcatheter-left-atrial-appendage-occlusion-(laao)-device/ 2025-08-28T13:39:15.369Z https://www.ace-hta.gov.sg/healthcare-professionals/ace-horizon-scanning/fibresolve-to-aid-in-the-diagnosis-of-idiopathic-pulmonary-fibrosis/ 2025-04-30T09:01:40.548Z https://www.ace-hta.gov.sg/healthcare-professionals/ace-horizon-scanning/guardant360-cdx-for-patients-with-locally-advanced-or-metastatic-non-small-cell-lung-cancer/ 2025-08-28T13:39:15.369Z https://www.ace-hta.gov.sg/healthcare-professionals/ace-horizon-scanning/heartflow-ffrct-for-the-diagnosis-of-coronary-artery-disease/ 2025-08-28T13:39:15.369Z https://www.ace-hta.gov.sg/healthcare-professionals/ace-horizon-scanning/kardiamobile-for-the-detection-of-atrial-fibrillation/ 2025-08-28T13:39:15.369Z https://www.ace-hta.gov.sg/healthcare-professionals/ace-horizon-scanning/kidneyintelx-for-patients-with-diabetic-kidney-disease/ 2025-08-28T13:39:15.369Z https://www.ace-hta.gov.sg/healthcare-professionals/ace-horizon-scanning/lumisystem/ 2025-11-20T08:02:50.053Z https://www.ace-hta.gov.sg/healthcare-professionals/ace-horizon-scanning/magtrace-and-sentimag-for-locating-sentinel-lymph-node-in-patients-with-breast-cancer/ 2025-08-28T13:39:15.369Z https://www.ace-hta.gov.sg/healthcare-professionals/ace-horizon-scanning/nerivio-for-the-acute-and-preventive-treatment-of-migraine/ 2025-08-28T13:39:15.369Z https://www.ace-hta.gov.sg/healthcare-professionals/ace-horizon-scanning/optune-for-the-treatment-of-newly-diagnosed-and-recurrent-glioblastoma/ 2025-08-28T13:39:15.369Z https://www.ace-hta.gov.sg/healthcare-professionals/ace-horizon-scanning/organ-care-system-(ocs)-heart-system-for-heart-transplantation-of-marginal-brain-death-donor-hearts-or-circulatory-death-donor-hearts/ 2025-08-28T13:39:15.369Z https://www.ace-hta.gov.sg/healthcare-professionals/ace-horizon-scanning/overview-of-clinical-applications-of-telemedicine/ 2025-08-28T13:39:15.369Z https://www.ace-hta.gov.sg/healthcare-professionals/ace-horizon-scanning/oxevision-for-vision-based-patient-monitoring-and-management-in-mental-health-wards/ 2025-08-28T13:39:15.369Z https://www.ace-hta.gov.sg/healthcare-professionals/ace-horizon-scanning/paige-prostate-detect-to-assist-the-diagnosis-of-prostate-cancer/ 2025-08-28T13:39:15.369Z https://www.ace-hta.gov.sg/healthcare-professionals/ace-horizon-scanning/phagenyx-to-improve-swallowing-in-severe-post-stroke-dysphagia/ 2026-01-29T05:45:14.056Z https://www.ace-hta.gov.sg/healthcare-professionals/ace-horizon-scanning/pons/ 2025-11-20T08:14:21.515Z https://www.ace-hta.gov.sg/healthcare-professionals/ace-horizon-scanning/rapid-to-aid-the-diagnosis-of-patients-suspected-of-stroke/ 2025-08-28T13:39:15.369Z https://www.ace-hta.gov.sg/healthcare-professionals/ace-horizon-scanning/relievrx-for-the-treatment-of-chronic-lower-back-pain/ 2025-08-28T13:39:15.369Z https://www.ace-hta.gov.sg/healthcare-professionals/ace-horizon-scanning/revivent-tc-transcatheter-ventricular-enhancement-system-for-ischemic-heart-failure/ 2025-08-28T13:39:15.369Z https://www.ace-hta.gov.sg/healthcare-professionals/ace-horizon-scanning/the-cadscor-system-as-a-rule-out-test-for-symptomatic-patients-suspected-to-have-coronary-artery-disease/ 2025-08-28T13:39:15.369Z https://www.ace-hta.gov.sg/healthcare-professionals/ace-horizon-scanning/the-precivityad-test-for-the-prognosis-of-alzheimer's-disease/ 2025-08-28T13:39:15.369Z https://www.ace-hta.gov.sg/healthcare-professionals/ace-horizon-scanning/the-signatera-test-for-patients-previously-diagnosed-with-cancer/ 2025-08-28T13:39:15.369Z https://www.ace-hta.gov.sg/healthcare-professionals/ace-horizon-scanning/transcutaneous-afferent-patterned-stimulation-for-patients-with-essential-tremor-or-parkinsons-disease/ 2025-08-28T13:39:15.369Z https://www.ace-hta.gov.sg/healthcare-professionals/ace-horizon-scanning/vagus-nerve-stimulation-with-the-vitaria-system-for-heart-failure-with-reduced-ejection-fraction/ 2025-08-28T13:39:15.369Z https://www.ace-hta.gov.sg/healthcare-professionals/ace-horizon-scanning/zio-xt-for-ambulatory-ecg-monitoring-for-patients-suspected-to-have-cardiac-arrhythmia/ 2025-08-28T13:39:15.369Z https://www.ace-hta.gov.sg/healthcare-professionals/ace-repository-for-clinical-guidelines-overview/ 2026-03-11T09:01:24.980Z https://www.ace-hta.gov.sg/healthcare-professionals/ace-repository-for-clinical-guidelines/ 2026-03-06T02:58:47.757Z https://www.ace-hta.gov.sg/healthcare-professionals/ace-repository-for-clinical-guidelines/asthma-optimising-long-term-management-with-inhaled-corticosteroid/ 2026-02-27T08:01:56.133Z https://www.ace-hta.gov.sg/healthcare-professionals/ace-repository-for-clinical-guidelines/chronic-kidney-disease-delaying-progression-and-reducing-cardiovascular-complications/ 2026-02-16T03:38:06.276Z https://www.ace-hta.gov.sg/healthcare-professionals/ace-repository-for-clinical-guidelines/chronic-kidney-disease-early-detection/ 2025-12-11T06:08:07.710Z https://www.ace-hta.gov.sg/healthcare-professionals/ace-repository-for-clinical-guidelines/chronic-obstructive-pulmonary-disease-diagnosis-and-management/ 2026-03-05T08:25:37.020Z https://www.ace-hta.gov.sg/healthcare-professionals/ace-repository-for-clinical-guidelines/foot-assessment-in-patients-with-diabetes-mellitus/ 2026-03-05T08:28:09.826Z https://www.ace-hta.gov.sg/healthcare-professionals/ace-repository-for-clinical-guidelines/generalised-anxiety-disorder-easing-burden-and-enabling-remission/ 2026-03-12T03:45:46.912Z https://www.ace-hta.gov.sg/healthcare-professionals/ace-repository-for-clinical-guidelines/gestational-diabetes-mellitus-an-update-on-screening-diagnosis-and-follow-up/ 2025-12-12T06:39:22.677Z https://www.ace-hta.gov.sg/healthcare-professionals/ace-repository-for-clinical-guidelines/gout-achieving-the-management-goal-2023/ 2026-03-05T08:30:18.694Z https://www.ace-hta.gov.sg/healthcare-professionals/ace-repository-for-clinical-guidelines/hypertension-tailoring-the-management-plan-to-optimise-blood-pressure-control/ 2026-03-05T08:20:24.909Z https://www.ace-hta.gov.sg/healthcare-professionals/ace-repository-for-clinical-guidelines/initiating-basal-insulin-in-type-2-diabetes-mellitus/ 2026-03-05T08:32:33.332Z https://www.ace-hta.gov.sg/healthcare-professionals/ace-repository-for-clinical-guidelines/lipid-management-focus-on-cardiovascular-risk/ 2026-03-05T08:34:25.551Z https://www.ace-hta.gov.sg/healthcare-professionals/ace-repository-for-clinical-guidelines/major-depressive-disorder-achieving-and-sustaining-remission/ 2026-03-05T08:40:26.016Z https://www.ace-hta.gov.sg/healthcare-professionals/ace-repository-for-clinical-guidelines/management-of-chronic-coronary-syndrome/ 2026-03-25T08:47:51.424Z https://www.ace-hta.gov.sg/healthcare-professionals/ace-repository-for-clinical-guidelines/managing-pre-diabetes-a-growing-health-concern/ 2025-12-11T06:35:34.817Z https://www.ace-hta.gov.sg/healthcare-professionals/ace-repository-for-clinical-guidelines/mild-and-moderate-atopic-dermatitis-acg/ 2026-03-31T03:47:01.904Z https://www.ace-hta.gov.sg/healthcare-professionals/ace-repository-for-clinical-guidelines/oral-anticoagulation-for-atrial-fibrillation/ 2026-03-05T08:43:27.915Z https://www.ace-hta.gov.sg/healthcare-professionals/ace-repository-for-clinical-guidelines/osteoporosis--diagnosis-and-management/ 2026-02-27T07:46:07.164Z https://www.ace-hta.gov.sg/healthcare-professionals/ace-repository-for-clinical-guidelines/promoting-smoking-cessation-and-treating-tobacco-dependence/ 2026-03-05T08:45:33.950Z https://www.ace-hta.gov.sg/healthcare-professionals/ace-repository-for-clinical-guidelines/singapore-national-dengue-guideline/ 2026-03-31T08:08:59.487Z https://www.ace-hta.gov.sg/healthcare-professionals/ace-repository-for-clinical-guidelines/t2dm-personalising-medications/ 2025-12-11T06:42:31.059Z https://www.ace-hta.gov.sg/healthcare-professionals/ace-repository-for-clinical-guidelines/urinary-tract-infections-appropriate-diagnosis-and-antibiotic-use-for-uncomplicated-cystitis-and-pyelonephritis/ 2026-03-05T08:48:06.359Z https://www.ace-hta.gov.sg/healthcare-professionals/ace-repository-for-clinical-guidelines/venous-thromboembolism-treating-with-the-appropriate-anticoagulant-and-duration/ 2026-03-05T08:50:18.205Z https://www.ace-hta.gov.sg/healthcare-professionals/ace-repository-for-clinical-guidelines/when-not-to-order-chest-x-ray/ 2025-12-11T06:47:07.159Z https://www.ace-hta.gov.sg/healthcare-professionals/ace-repository-for-clinical-guidelines/when-to-order-ct-mri-for-headache/ 2025-10-16T02:59:26.389Z https://www.ace-hta.gov.sg/healthcare-professionals/ace-repository-for-clinical-guidelines/when-to-order-mri-for-low-back-pain/ 2025-12-11T06:49:20.781Z https://www.ace-hta.gov.sg/healthcare-professionals/ace-technology-guidances/ 2026-04-02T07:18:49.612Z https://www.ace-hta.gov.sg/healthcare-professionals/ace-technology-guidances/drug-guidance/ 2025-08-28T13:39:19.433Z https://www.ace-hta.gov.sg/healthcare-professionals/ace-technology-guidances/drug-guidance/abiraterone-for-treating-metastatic-prostate-cancer/ 2025-08-28T13:39:19.433Z https://www.ace-hta.gov.sg/healthcare-professionals/ace-technology-guidances/drug-guidance/abrocitinib-baricitinib-upadacitinib-and-dupilumab-for-treating-atopic-dermatitis/ 2025-08-28T13:39:19.433Z https://www.ace-hta.gov.sg/healthcare-professionals/ace-technology-guidances/drug-guidance/acalabrutinib-bortezomib-and-ibrutinib-for-treating-mantle-cell-lymphoma/ 2025-08-28T13:39:19.433Z https://www.ace-hta.gov.sg/healthcare-professionals/ace-technology-guidances/drug-guidance/acarbose-for-treating-type-2-diabetes-mellitus/ 2025-08-28T13:39:19.433Z https://www.ace-hta.gov.sg/healthcare-professionals/ace-technology-guidances/drug-guidance/adalimumab-for-treating-inflammatory-conditions/ 2025-12-12T01:04:37.175Z https://www.ace-hta.gov.sg/healthcare-professionals/ace-technology-guidances/drug-guidance/aflibercept-and-faricimab-for-treating-macular-oedema-secondary-to-retinal-vein-occlusion/ 2025-09-16T09:47:30.631Z https://www.ace-hta.gov.sg/healthcare-professionals/ace-technology-guidances/drug-guidance/aflibercept-bevacizumab-and-ramucirumab-for-treating-metastatic-colorectal-cancer/ 2025-08-28T13:39:19.433Z https://www.ace-hta.gov.sg/healthcare-professionals/ace-technology-guidances/drug-guidance/alectinib-for-adjuvant-treatment-of-resectable--alk-mutation-positive-non-small-cell-lung-cancer/ 2025-09-16T14:04:27.769Z https://www.ace-hta.gov.sg/healthcare-professionals/ace-technology-guidances/drug-guidance/amivantamab-for-previously-treated--locally-advanced-or-metastatic-egfr-exon-19-deletion-or-exon-21-l858r-substitution-mutation-positive-non-small-cell-lung-cancer/ 2026-02-06T06:16:30.631Z https://www.ace-hta.gov.sg/healthcare-professionals/ace-technology-guidances/drug-guidance/amivantamab-for-previously-untreated--locally-advanced-or-metastatic-egfr-exon-20-insertion-mutation-positive-non-small-cell-lung-cancer/ 2026-02-06T06:27:10.399Z https://www.ace-hta.gov.sg/healthcare-professionals/ace-technology-guidances/drug-guidance/anti-vascular-endothelial-growth-factors-for-treating-diabetic-macular-oedema-and-age-related-macular-degeneration/ 2025-09-16T07:44:36.823Z https://www.ace-hta.gov.sg/healthcare-professionals/ace-technology-guidances/drug-guidance/antiretroviral-therapies-for-treating-human-immunodeficiency-virus-type-1-(hiv-1)-infection/ 2025-08-28T13:39:19.433Z https://www.ace-hta.gov.sg/healthcare-professionals/ace-technology-guidances/drug-guidance/asciminib-for-philadelphia-chromosome-positive-chronic-myeloid-leukaemia-in-chronic-phase-after-two-or-more-tyrosine-kinase-inhibitors/ 2026-02-08T00:46:04.114Z https://www.ace-hta.gov.sg/healthcare-professionals/ace-technology-guidances/drug-guidance/atogepant-and-rimegepant-for-prophylaxis-of-migraine/ 2025-08-28T13:39:19.433Z https://www.ace-hta.gov.sg/healthcare-professionals/ace-technology-guidances/drug-guidance/axicabtagene-ciloleucel--for-relapsed-or-refractory-large-b-cell-lymphoma-after-two-or-more-lines-of-systemic-therapy/ 2025-08-28T13:39:19.433Z https://www.ace-hta.gov.sg/healthcare-professionals/ace-technology-guidances/drug-guidance/axicabtagene-ciloleucel--for-second-line-relapsed-or-refractory-large-b-cell-lymphoma/ 2025-08-28T13:39:19.433Z https://www.ace-hta.gov.sg/healthcare-professionals/ace-technology-guidances/drug-guidance/bevacizumab-biosimilar-for-treating-different-types-of-cancer/ 2025-10-08T03:23:14.091Z https://www.ace-hta.gov.sg/healthcare-professionals/ace-technology-guidances/drug-guidance/bevacizumab-for-treating-persistent-recurrent-or-metastatic-cervical-cancer/ 2025-08-28T13:39:19.433Z https://www.ace-hta.gov.sg/healthcare-professionals/ace-technology-guidances/drug-guidance/biologics-and-janus-kinase-inhibitors-after-conventional-disease-modifying-antirheumatic-drugs-for-treating-rheumatoid-arthritis/ 2025-08-28T13:39:19.433Z https://www.ace-hta.gov.sg/healthcare-professionals/ace-technology-guidances/drug-guidance/biologics-as-add-on-therapy-for-severe-asthma/ 2026-03-06T05:19:00.686Z https://www.ace-hta.gov.sg/healthcare-professionals/ace-technology-guidances/drug-guidance/blinatumomab-for-newly-diagnosed-b-precursor-acute-lymphoblastic-leukaemia-in-the-consolidation-phase-of-chemotherapy-/ 2026-02-06T08:04:26.118Z https://www.ace-hta.gov.sg/healthcare-professionals/ace-technology-guidances/drug-guidance/blinatumomab-for-treating-relapsed-or-refractory-b-precursor-acute-lymphoblastic-leukaemia/ 2026-04-01T01:10:52.583Z https://www.ace-hta.gov.sg/healthcare-professionals/ace-technology-guidances/drug-guidance/botulinum-toxin-a-for-treating-adults-with-focal-spasticity-of-the-lower-limbs-associated-with-stroke-in-adults/ 2025-09-16T07:11:43.829Z https://www.ace-hta.gov.sg/healthcare-professionals/ace-technology-guidances/drug-guidance/botulinum-toxin-a-for-the-management-of-focal-spasticity-of-the-upper-limbs-associated-with-stroke-in-adults/ 2025-09-16T07:12:06.892Z https://www.ace-hta.gov.sg/healthcare-professionals/ace-technology-guidances/drug-guidance/botulinum-toxin-a-for-treating-blepharospasm-or-hemifacial-spasm/ 2025-09-16T07:13:47.231Z https://www.ace-hta.gov.sg/healthcare-professionals/ace-technology-guidances/drug-guidance/botulinum-toxin-a-for-treating-cervical-dystonia/ 2025-09-16T07:13:29.518Z https://www.ace-hta.gov.sg/healthcare-professionals/ace-technology-guidances/drug-guidance/botulinum-toxin-a-for-treating-focal-spasticity-of-the-upper-or-lower-limbs-in-children-with-cerebral-palsy/ 2025-09-16T07:14:16.252Z https://www.ace-hta.gov.sg/healthcare-professionals/ace-technology-guidances/drug-guidance/botulinum-toxin-type-a-for-the-prophylaxis-of-headaches-in-adults-with-chronic-migraine/ 2025-08-28T13:39:19.433Z https://www.ace-hta.gov.sg/healthcare-professionals/ace-technology-guidances/drug-guidance/brentuximab-vedotin-for-treating-t-cell-lymphoma/ 2025-08-28T13:39:19.433Z https://www.ace-hta.gov.sg/healthcare-professionals/ace-technology-guidances/drug-guidance/budesonide-prolonged-release-tablet-for-treating-mild-to-moderate-active-ulcerative-colitis/ 2025-08-28T13:39:19.433Z https://www.ace-hta.gov.sg/healthcare-professionals/ace-technology-guidances/drug-guidance/burosumab-for-treating-x-linked-hypophosphataemia/ 2025-08-28T13:39:19.433Z https://www.ace-hta.gov.sg/healthcare-professionals/ace-technology-guidances/drug-guidance/cabotegravir-with-rilpivirine---for-treating-human-immunodeficiency-virus-type-1-(hiv-1)-infection/ 2025-08-28T13:39:19.433Z https://www.ace-hta.gov.sg/healthcare-professionals/ace-technology-guidances/drug-guidance/cabozantinib-in-combination-with-nivolumab-for-previously-untreated-advanced-renal-cell-cancer/ 2025-08-28T13:39:19.433Z https://www.ace-hta.gov.sg/healthcare-professionals/ace-technology-guidances/drug-guidance/calcitonin-gene-related-peptide-monoclonal-antibodies-for-prophylaxis-of-migraine/ 2025-08-28T13:39:19.433Z https://www.ace-hta.gov.sg/healthcare-professionals/ace-technology-guidances/drug-guidance/capivasertib-in-combination-with-fulvestrant-for-hr-positive--her2-negative--locally-advanced-or-metastatic-breast-cancer-with-one-or-more-pik3ca-akt1-pten-alteration/ 2026-02-08T00:50:19.404Z https://www.ace-hta.gov.sg/healthcare-professionals/ace-technology-guidances/drug-guidance/carbonic-anhydrase-inhibitor-eye-drops-for-treating-open-angle-glaucoma-or-ocular-hypertension/ 2025-08-28T13:39:19.433Z https://www.ace-hta.gov.sg/healthcare-professionals/ace-technology-guidances/drug-guidance/cetuximab-and-panitumumab-for-treating-ras-wild-type-colorectal-cancer/ 2025-08-28T13:39:19.433Z https://www.ace-hta.gov.sg/healthcare-professionals/ace-technology-guidances/drug-guidance/ciclosporin-0-1-eye-drops-for-treating-severe-keratitis-in-dry-eye-disease/ 2025-08-28T13:39:19.433Z https://www.ace-hta.gov.sg/healthcare-professionals/ace-technology-guidances/drug-guidance/ciclosporin-eye-drops-for-treating-severe-vernal-keratoconjunctivitis/ 2025-08-28T13:39:19.433Z https://www.ace-hta.gov.sg/healthcare-professionals/ace-technology-guidances/drug-guidance/complement-inhibitors-for-treating-paroxysmal-nocturnal-haemoglobinuria-and-atypical-haemolytic-uraemic-syndrome/ 2026-02-06T04:49:56.120Z https://www.ace-hta.gov.sg/healthcare-professionals/ace-technology-guidances/drug-guidance/crisaborole-ointment-for-treating-atopic-dermatitis/ 2025-08-28T13:39:19.433Z https://www.ace-hta.gov.sg/healthcare-professionals/ace-technology-guidances/drug-guidance/dabrafenib-in-combination-with-trametinib-for-low-grade-glioma-and-relapsed-or-refractory-high-grade-glioma--with-braf-v600e-mutations/ 2026-02-06T08:13:56.567Z https://www.ace-hta.gov.sg/healthcare-professionals/ace-technology-guidances/drug-guidance/dabrafenib-in-combination-with-trametinib-for-treating-braf-v600-mutation-positive-anaplastic-thyroid-cancer/ 2025-08-28T13:39:19.433Z https://www.ace-hta.gov.sg/healthcare-professionals/ace-technology-guidances/drug-guidance/dacomitinib-for-treating-egfr-mutation-positive-non-small-cell-lung-cancer/ 2025-08-28T13:39:19.433Z https://www.ace-hta.gov.sg/healthcare-professionals/ace-technology-guidances/drug-guidance/daratumumab-for-treating-newly-diagnosed-light-chain-(al)-amyloidosis/ 2025-08-28T13:39:19.433Z https://www.ace-hta.gov.sg/healthcare-professionals/ace-technology-guidances/drug-guidance/daratumumab-based-regimens-for-newly-diagnosed-multiple-myeloma/ 2025-11-01T00:02:23.911Z https://www.ace-hta.gov.sg/healthcare-professionals/ace-technology-guidances/drug-guidance/darolutamide--for-treating-prostate-cancer/ 2025-08-28T13:39:19.433Z https://www.ace-hta.gov.sg/healthcare-professionals/ace-technology-guidances/drug-guidance/datopotamab-deruxtecan-for-previously-treated-unresectable-or-metastatic-hr-positive--her2-negative-breast-cancer/ 2025-11-04T02:07:03.882Z https://www.ace-hta.gov.sg/healthcare-professionals/ace-technology-guidances/drug-guidance/denosumab-for-the-prevention-of-skeletal-related-events-in-adults-with-bone-metastases-from-solid-tumours/ 2025-08-28T13:39:19.433Z https://www.ace-hta.gov.sg/healthcare-professionals/ace-technology-guidances/drug-guidance/denosumab-for-the-treatment-of-postmenopausal-women-with-osteoporosis-at-high-risk-of-fracture/ 2025-08-28T13:39:19.433Z https://www.ace-hta.gov.sg/healthcare-professionals/ace-technology-guidances/drug-guidance/deucravacitinib-for-moderate-to-severe-chronic-plaque-psoriasis/ 2025-08-28T13:39:19.433Z https://www.ace-hta.gov.sg/healthcare-professionals/ace-technology-guidances/drug-guidance/dexamethasone-intravitreal-implant-for-treating-diabetic-macular-oedema-retinal-vein-occlusion-and-non-infectious-uveitis/ 2025-08-28T13:39:19.433Z https://www.ace-hta.gov.sg/healthcare-professionals/ace-technology-guidances/drug-guidance/direct-acting-antiviral-agents-for-treating-chronic-hepatitis-c/ 2025-08-28T13:39:19.433Z https://www.ace-hta.gov.sg/healthcare-professionals/ace-technology-guidances/drug-guidance/disease-modifying-therapies-for-treating-multiple-sclerosis/ 2025-08-28T13:39:19.433Z https://www.ace-hta.gov.sg/healthcare-professionals/ace-technology-guidances/drug-guidance/dolutegravir-with-lamivudine-for-treating-human-immunodeficiency-virus-type-1-(hiv-1)-infection/ 2025-08-28T13:39:19.433Z https://www.ace-hta.gov.sg/healthcare-professionals/ace-technology-guidances/drug-guidance/donanemab-and-lecanemab-for-treating-mild--cognitive-impairment-and-mild-dementia-due-to-alzheimer-s-disease/ 2026-02-06T07:04:04.024Z https://www.ace-hta.gov.sg/healthcare-professionals/ace-technology-guidances/drug-guidance/dostarlimab--for-treating-dmmr-or-msi-h-primary-advanced-or-recurrent-endometrial-cancer/ 2025-09-16T14:03:42.540Z https://www.ace-hta.gov.sg/healthcare-professionals/ace-technology-guidances/drug-guidance/durvalumab-in-combination-with-tremelimumab-for-treating-unresectable-hepatocellular-carcinoma/ 2025-08-28T13:39:19.433Z https://www.ace-hta.gov.sg/healthcare-professionals/ace-technology-guidances/drug-guidance/durvalumab-with-or-without-olaparib-for-treating-primary-advanced-or-recurrent-endometrial-cancer/ 2025-09-16T09:35:25.319Z https://www.ace-hta.gov.sg/healthcare-professionals/ace-technology-guidances/drug-guidance/dutasteride-tamsulosin-alfuzosin-and-dutasteride-tamsulosin-combination-for-treating-benign-prostatic-hyperplasia/ 2025-08-28T13:39:19.433Z https://www.ace-hta.gov.sg/healthcare-professionals/ace-technology-guidances/drug-guidance/echinocandins-for-treating-invasive-candidiasis/ 2025-08-28T13:39:19.433Z https://www.ace-hta.gov.sg/healthcare-professionals/ace-technology-guidances/drug-guidance/eltrombopag-for-treating-immune-thrombocytopenia-and-severe-aplastic-anaemia/ 2025-08-28T13:39:19.433Z https://www.ace-hta.gov.sg/healthcare-professionals/ace-technology-guidances/drug-guidance/emicizumab-prophylaxis-for-patients-with-haemophilia-a/ 2025-08-28T13:39:19.433Z https://www.ace-hta.gov.sg/healthcare-professionals/ace-technology-guidances/drug-guidance/endothelin-receptor-antagonists-for-treating-pulmonary-arterial-hypertension/ 2025-08-28T13:39:19.433Z https://www.ace-hta.gov.sg/healthcare-professionals/ace-technology-guidances/drug-guidance/enzyme-replacement-therapies-for-fabry-disease/ 2025-08-28T13:39:19.433Z https://www.ace-hta.gov.sg/healthcare-professionals/ace-technology-guidances/drug-guidance/epcoritamab-for-relapsed-or-refractory-diffuse-large-b-cell-lymphoma-after-two-or-more-lines-of-systemic-therapy/ 2025-09-24T09:43:31.070Z https://www.ace-hta.gov.sg/healthcare-professionals/ace-technology-guidances/drug-guidance/eplontersen-and-vutrisiran-for-hereditary-transthyretin-amyloidosis-with-polyneuropathy/ 2026-02-06T05:15:21.769Z https://www.ace-hta.gov.sg/healthcare-professionals/ace-technology-guidances/drug-guidance/everolimus-lanreotide-octreotide-and-sunitinib-for-treating-advanced-neuroendocrine-tumours/ 2025-08-28T13:39:19.433Z https://www.ace-hta.gov.sg/healthcare-professionals/ace-technology-guidances/drug-guidance/ezetimibe-and-ezetimibe-simvastatin-for-treating-primary-hypercholesterolaemia/ 2025-08-28T13:39:19.433Z https://www.ace-hta.gov.sg/healthcare-professionals/ace-technology-guidances/drug-guidance/febuxostat-for-treating-chronic-hyperuricaemia-in-adults-with-gout/ 2025-08-28T13:39:19.433Z https://www.ace-hta.gov.sg/healthcare-professionals/ace-technology-guidances/drug-guidance/ferric-carboxymaltose-for-treating-iron-deficiency-anaemia/ 2025-08-28T13:39:19.433Z https://www.ace-hta.gov.sg/healthcare-professionals/ace-technology-guidances/drug-guidance/ferric-derisomaltose-for-treating-iron-deficiency-anemia/ 2025-08-28T13:39:19.433Z https://www.ace-hta.gov.sg/healthcare-professionals/ace-technology-guidances/drug-guidance/finerenone-for-treating-chronic-kidney-disease-and-albuminuria-associated-with-type-2-diabetes/ 2025-09-16T09:56:04.263Z https://www.ace-hta.gov.sg/healthcare-professionals/ace-technology-guidances/drug-guidance/fruquintinib-for-previously-treated-metastatic-colorectal-cancer/ 2025-09-16T07:37:54.910Z https://www.ace-hta.gov.sg/healthcare-professionals/ace-technology-guidances/drug-guidance/gemcitabine-for-the-treatment-of-cancer/ 2025-08-28T13:39:19.433Z https://www.ace-hta.gov.sg/healthcare-professionals/ace-technology-guidances/drug-guidance/gemtuzumab-ozogamicin-for-untreated-de-novo-cd33-positive-acute-myeloid-leukaemia/ 2025-08-28T13:39:19.433Z https://www.ace-hta.gov.sg/healthcare-professionals/ace-technology-guidances/drug-guidance/gliclazide-for-the-treatment-of-type-2-diabetes-mellitus/ 2025-08-28T13:39:19.433Z https://www.ace-hta.gov.sg/healthcare-professionals/ace-technology-guidances/drug-guidance/glofitamab-for-relapsed-or-refractory-diffuse-large-b-cell-lymphoma-after-two-or-more-lines-of-systemic-therapy/ 2025-08-28T13:39:19.433Z https://www.ace-hta.gov.sg/healthcare-professionals/ace-technology-guidances/drug-guidance/glp-1-receptor-agonist-injections-for-treating-type-2-diabetes-mellitus/ 2025-08-28T13:39:19.433Z https://www.ace-hta.gov.sg/healthcare-professionals/ace-technology-guidances/drug-guidance/golimumab-for-the-treatment-of-rheumatoid-arthritis-psoriatic-arthritis-ankylosing-spondylitis-and-ulcerative-colitis/ 2025-08-28T13:39:19.433Z https://www.ace-hta.gov.sg/healthcare-professionals/ace-technology-guidances/drug-guidance/guselkumab-ixekizumab-and-secukinumab-for-treating-chronic-plaque-psoriasis/ 2025-08-28T13:39:19.433Z https://www.ace-hta.gov.sg/healthcare-professionals/ace-technology-guidances/drug-guidance/high-strength-insulin-glargine-for-treating-type-1-and-2-diabetes-mellitus/ 2025-08-28T13:39:19.433Z https://www.ace-hta.gov.sg/healthcare-professionals/ace-technology-guidances/drug-guidance/immune-checkpoint-inhibitors-and-brak-mek-inhibitors-for-treating-advanced-malignant-melanoma/ 2025-09-08T01:18:51.656Z https://www.ace-hta.gov.sg/healthcare-professionals/ace-technology-guidances/drug-guidance/inavolisib-in-combination-with-palbociclib-and-fulvestrant-for-pik3ca-mutated--hr-positive--her2-negative--locally-advanced-or-metastatic-breast-cancer/ 2026-02-08T00:38:14.135Z https://www.ace-hta.gov.sg/healthcare-professionals/ace-technology-guidances/drug-guidance/inhaled-corticosteroids-with-long-acting-beta-2-agonists-for-treating-asthma/ 2025-08-28T13:39:19.433Z https://www.ace-hta.gov.sg/healthcare-professionals/ace-technology-guidances/drug-guidance/insulin-aspart-(fiasp)-for-treating-diabetes-mellitus/ 2025-08-28T13:39:19.433Z https://www.ace-hta.gov.sg/healthcare-professionals/ace-technology-guidances/drug-guidance/insulin-glargine-biosimilar-(basaglar)-for-the-treatment-of-type-1-and-type-2-diabetes-mellitus/ 2025-08-28T13:39:19.433Z https://www.ace-hta.gov.sg/healthcare-professionals/ace-technology-guidances/drug-guidance/infliximab-biosimilar-for-treating-inflammatory-condition/ 2025-08-28T13:39:19.433Z https://www.ace-hta.gov.sg/healthcare-professionals/ace-technology-guidances/drug-guidance/intravenous-proton-pump-inhibitors-for-gastric-anti-secretory-treatment-when-oral-therapies-are-unsuitable/ 2025-08-28T13:39:19.433Z https://www.ace-hta.gov.sg/healthcare-professionals/ace-technology-guidances/drug-guidance/ivabradine-for-the-treatment-of-chronic-stable-angina-and-chronic-heart-failure/ 2025-08-28T13:39:19.433Z https://www.ace-hta.gov.sg/healthcare-professionals/ace-technology-guidances/drug-guidance/ixekizumab-and-secukinumab-for-treating-active-ankylosing-spondylitis/ 2025-08-28T13:39:19.433Z https://www.ace-hta.gov.sg/healthcare-professionals/ace-technology-guidances/drug-guidance/ixekizumab-and-secukinumab-for-treating-active-non-radiographic-axial-spondyloarthritis/ 2025-08-28T13:39:19.433Z https://www.ace-hta.gov.sg/healthcare-professionals/ace-technology-guidances/drug-guidance/ixekizumab-and-secukinumab-for-treating-active-psoriatic-arthritis/ 2025-08-28T13:39:19.433Z https://www.ace-hta.gov.sg/healthcare-professionals/ace-technology-guidances/drug-guidance/lama-lama-laba-for-chronic-obstructive-pulmonary-disease-(copd)/ 2025-08-28T13:39:19.433Z https://www.ace-hta.gov.sg/healthcare-professionals/ace-technology-guidances/drug-guidance/lanthanum-carbonate-and-sevelamer-carbonate-for-treating-hyperphosphataemia-in-patients-with-chronic-kidney-disease/ 2025-08-28T13:39:19.433Z https://www.ace-hta.gov.sg/healthcare-professionals/ace-technology-guidances/drug-guidance/lenvatinib-and-sorafenib-for-treating-advanced-hepatocellular-carcinoma/ 2025-08-28T13:39:19.433Z https://www.ace-hta.gov.sg/healthcare-professionals/ace-technology-guidances/drug-guidance/lenvatinib-and-sorafenib-for-treating-differentiated-thyroid-cancer/ 2025-08-28T13:39:19.433Z https://www.ace-hta.gov.sg/healthcare-professionals/ace-technology-guidances/drug-guidance/long-acting-erythropoiesis-stimulating-agents-for-treating-anaemia-in-chronic-kidney-disease/ 2025-03-20T11:30:41.037Z https://www.ace-hta.gov.sg/healthcare-professionals/ace-technology-guidances/drug-guidance/mavacamten-for-treating-obstructive-hypertrophic-cardiomyopathy/ 2025-08-28T13:39:19.433Z https://www.ace-hta.gov.sg/healthcare-professionals/ace-technology-guidances/drug-guidance/metformin-extended-release-for-treating-type-2-diabetes-mellitus/ 2025-08-28T13:39:19.433Z https://www.ace-hta.gov.sg/healthcare-professionals/ace-technology-guidances/drug-guidance/momelotinib-for-treating-myelofibrosis-in-patients-with-moderate-to-severe-anaemia/ 2026-02-06T05:53:49.958Z https://www.ace-hta.gov.sg/healthcare-professionals/ace-technology-guidances/drug-guidance/mycophenolate-mofetil-for-immunosuppression/ 2025-12-12T01:05:27.180Z https://www.ace-hta.gov.sg/healthcare-professionals/ace-technology-guidances/drug-guidance/nicotine-replacement-therapies-to-aid-smoking-cessation/ 2025-08-28T13:39:19.433Z https://www.ace-hta.gov.sg/healthcare-professionals/ace-technology-guidances/drug-guidance/nintedanib-and-pirfenidone-for-treating-idiopathic-pulmonary-fibrosis/ 2025-08-28T13:39:19.433Z https://www.ace-hta.gov.sg/healthcare-professionals/ace-technology-guidances/drug-guidance/nirmatrelvir-and-ritonavir-combination-for-treating-mild-to-moderate-covid-19/ 2026-03-31T23:42:45.321Z https://www.ace-hta.gov.sg/healthcare-professionals/ace-technology-guidances/drug-guidance/nivolumab-for-treating-gastroesophageal-cancers/ 2026-03-31T23:56:12.759Z https://www.ace-hta.gov.sg/healthcare-professionals/ace-technology-guidances/drug-guidance/nivolumab-in-combination-with-ipilimumab-and-chemotherapy-for-untreated-metastatic-or-recurrent-non-small-cell-lung-cancer-in-patients-whose-tumours-express-pd-l1-with-a-tumour-proportion-score--1--with-no-egfr-or-alk-genomic-tumour-mutations/ 2026-02-06T08:18:29.481Z https://www.ace-hta.gov.sg/healthcare-professionals/ace-technology-guidances/drug-guidance/novel-oral-anticoagulants-(noacs)-for-the-prevention-of-stroke-and-systemic-embolism-in-non-valvular-atrial-fibrillation/ 2026-02-06T08:43:22.290Z https://www.ace-hta.gov.sg/healthcare-professionals/ace-technology-guidances/drug-guidance/non-vitamin-k-antagonist-oral-anti-coagulation-agents-(noacs)-for-the-treatment-and-secondary-prevention-of-venous-thromboembolism/ 2026-02-06T03:58:35.301Z https://www.ace-hta.gov.sg/healthcare-professionals/ace-technology-guidances/drug-guidance/nusinersen-and-risdiplam-for-treating-spinal-muscular-atrophy/ 2025-08-28T13:39:19.433Z https://www.ace-hta.gov.sg/healthcare-professionals/ace-technology-guidances/drug-guidance/olaparib-for-treating-germline-brca-mutated-her2-negative-high-risk-early-breast-cancer/ 2025-08-28T13:39:19.433Z https://www.ace-hta.gov.sg/healthcare-professionals/ace-technology-guidances/drug-guidance/omalizumab-biosimilar-for-treating-inflammatory-conditions/ 2026-03-06T05:20:07.914Z https://www.ace-hta.gov.sg/healthcare-professionals/ace-technology-guidances/drug-guidance/omalizumab-for-treating-antihistamine-resistant-chronic-spontaneous-urticaria/ 2026-02-06T03:54:16.540Z https://www.ace-hta.gov.sg/healthcare-professionals/ace-technology-guidances/drug-guidance/onasemnogene-abeparvovec-for-treating-spinal-muscular-atrophy/ 2025-09-17T00:42:44.031Z https://www.ace-hta.gov.sg/healthcare-professionals/ace-technology-guidances/drug-guidance/oral-cox-2-inhibitors-for-treating-pain/ 2025-08-28T13:39:19.433Z https://www.ace-hta.gov.sg/healthcare-professionals/ace-technology-guidances/drug-guidance/osimertinib-for-treating-egfr-mutation-positive-non-small-cell-lung-cancer/ 2025-08-28T13:39:19.433Z https://www.ace-hta.gov.sg/healthcare-professionals/ace-technology-guidances/drug-guidance/palivizumab-for-preventing-serious-lower-respiratory-tract-disease-caused-by-respiratory-syncytial-virus/ 2025-08-28T13:39:19.433Z https://www.ace-hta.gov.sg/healthcare-professionals/ace-technology-guidances/drug-guidance/parp-inhibitors-and-bevacizumab-for-treating-advanced-ovarian-cancer/ 2025-08-28T13:39:19.433Z https://www.ace-hta.gov.sg/healthcare-professionals/ace-technology-guidances/drug-guidance/pcsk9-inhibitors-for-treating-hypercholesterolaemia/ 2025-08-28T13:39:19.433Z https://www.ace-hta.gov.sg/healthcare-professionals/ace-technology-guidances/drug-guidance/pembrolizumab-for-the-adjuvant-treatment-of-renal-cell-carcinoma/ 2025-08-28T13:39:19.433Z https://www.ace-hta.gov.sg/healthcare-professionals/ace-technology-guidances/drug-guidance/pembrolizumab-for-treating-high-risk-early-stage-triple-negative-breast-cancer/ 2025-08-28T13:39:19.433Z https://www.ace-hta.gov.sg/healthcare-professionals/ace-technology-guidances/drug-guidance/pembrolizumab-for-treating-locally-advanced-unresectable-or-metastatic-her2-positive-gastric-or-gastroesophageal-junction-adenocarcinoma/ 2025-08-28T13:39:19.433Z https://www.ace-hta.gov.sg/healthcare-professionals/ace-technology-guidances/drug-guidance/pembrolizumab-for-treating-persistent-recurrent-or-metastatic-cervical-cancer/ 2025-09-08T01:20:08.088Z https://www.ace-hta.gov.sg/healthcare-professionals/ace-technology-guidances/drug-guidance/pembrolizumab-for-treating-resectable-stage-ii--iiia--or-iiib-(t3-4n2)-non-small-cell-lung-cancer/ 2025-08-28T13:39:19.433Z https://www.ace-hta.gov.sg/healthcare-professionals/ace-technology-guidances/drug-guidance/pneumococcal-conjugate-vaccines-(15-valent-and-20-valent)-for-the-prevention-of-pneumococcal-disease-in-adults/ 2025-08-28T13:39:19.433Z https://www.ace-hta.gov.sg/healthcare-professionals/ace-technology-guidances/drug-guidance/polatuzumab-vedotin-for-previously-untreated-diffuse-large-b-cell-lymphoma/ 2025-08-28T13:39:19.433Z https://www.ace-hta.gov.sg/healthcare-professionals/ace-technology-guidances/drug-guidance/polatuzumab-vedotin-for-treating-relapsed-or-refractory-diffuse-large-b-cell-lymphoma/ 2025-08-28T13:39:19.433Z https://www.ace-hta.gov.sg/healthcare-professionals/ace-technology-guidances/drug-guidance/poly-(adp-ribose)-polymerase-inhibitors-for-treating-brca-mutated-her2-negative-advanced-breast-cancer/ 2025-08-28T13:39:19.433Z https://www.ace-hta.gov.sg/healthcare-professionals/ace-technology-guidances/drug-guidance/pralsetinib-for-treating-ret-fusion-positive-locally-advanced-or-metastatic-non-small-cell-lung-cancer/ 2025-08-28T13:39:19.433Z https://www.ace-hta.gov.sg/healthcare-professionals/ace-technology-guidances/drug-guidance/prostaglandin-analogue-with-timolol-fixed-dose-combination-eye-drops-for-treatment-of-open-angle-glaucoma-or-ocular-hypertension/ 2025-08-28T13:39:19.433Z https://www.ace-hta.gov.sg/healthcare-professionals/ace-technology-guidances/drug-guidance/pulmonary-surfactant-for-treating-respiratory-distress-syndrome-in-premature-infants/ 2025-08-28T13:39:19.433Z https://www.ace-hta.gov.sg/healthcare-professionals/ace-technology-guidances/drug-guidance/ranibizumab-for-treating-age-related-macular-degeneration-diabetic-macular-oedema-and-retinal-vein-occlusion/ 2025-08-28T13:39:19.433Z https://www.ace-hta.gov.sg/healthcare-professionals/ace-technology-guidances/drug-guidance/recombinant-blood-products-for-prophylaxis-and-management-of-haemophilia-a-and-b/ 2025-08-28T13:39:19.433Z https://www.ace-hta.gov.sg/healthcare-professionals/ace-technology-guidances/drug-guidance/recombinant-zoster-vaccine-for-the-prevention-of-herpes-zoster-and-post-herpetic-neuralgia/ 2025-09-02T10:28:15.364Z https://www.ace-hta.gov.sg/healthcare-professionals/ace-technology-guidances/drug-guidance/regorafenib-and-sunitinib-for-treating-advanced-gastrointestinal-stromal-tumours/ 2025-08-28T13:39:19.433Z https://www.ace-hta.gov.sg/healthcare-professionals/ace-technology-guidances/drug-guidance/regorafenib-and-trifluridine-tipiracil-for-previously-treated-metastatic-colorectal-cancer/ 2025-08-28T13:39:19.433Z https://www.ace-hta.gov.sg/healthcare-professionals/ace-technology-guidances/drug-guidance/review-of-cancer-drugs-for-acute-lymphoblastic-leukaemia/ 2026-04-01T00:30:57.760Z https://www.ace-hta.gov.sg/healthcare-professionals/ace-technology-guidances/drug-guidance/review-of-cancer-drugs-for-chronic-lymphocytic-leukaemia/ 2025-08-28T13:39:19.433Z https://www.ace-hta.gov.sg/healthcare-professionals/ace-technology-guidances/drug-guidance/review-of-cancer-drugs-for-previously-treated-advanced-gastric-cancer/ 2026-04-01T00:12:26.128Z https://www.ace-hta.gov.sg/healthcare-professionals/ace-technology-guidances/drug-guidance/review-of-cancer-drugs-for-previously-treated-advanced-hepatocellular-carcinoma/ 2025-09-08T01:21:42.344Z https://www.ace-hta.gov.sg/healthcare-professionals/ace-technology-guidances/drug-guidance/review-of-cancer-drugs-for-previously-treated-multiple-myeloma/ 2025-11-01T00:13:13.808Z https://www.ace-hta.gov.sg/healthcare-professionals/ace-technology-guidances/drug-guidance/review-of-cancer-drugs-for-prostate-cancer/ 2025-03-20T11:30:43.566Z https://www.ace-hta.gov.sg/healthcare-professionals/ace-technology-guidances/drug-guidance/review-of-cancer-drugs-for-treating-advanced-urothelial-carcinoma/ 2026-04-01T00:07:29.931Z https://www.ace-hta.gov.sg/healthcare-professionals/ace-technology-guidances/drug-guidance/review-of-cancer-drugs-for-treating-early-or-advanced-her2-positive-breast-cancer/ 2025-08-28T13:39:19.433Z https://www.ace-hta.gov.sg/healthcare-professionals/ace-technology-guidances/drug-guidance/review-of-cancer-supportive-care-medicines/ 2025-08-28T13:39:19.433Z https://www.ace-hta.gov.sg/healthcare-professionals/ace-technology-guidances/drug-guidance/ribociclib-for-the-adjuvant-treatment-of-hr-positive--her2-negative-stage-ii-and-iii-early-breast-cancer-at-high-risk-of-recurrence/ 2026-02-08T00:41:32.160Z https://www.ace-hta.gov.sg/healthcare-professionals/ace-technology-guidances/drug-guidance/rifaximin-for-reducing-recurrent-episodes-of-overt-hepatic-encephalopathy/ 2025-08-28T13:39:19.433Z https://www.ace-hta.gov.sg/healthcare-professionals/ace-technology-guidances/drug-guidance/rituximab-for-treating-non-hodgkin-s-lymphoma-and-chronic-lymphocytic-leukaemia/ 2025-08-28T13:39:19.433Z https://www.ace-hta.gov.sg/healthcare-professionals/ace-technology-guidances/drug-guidance/rivastigmine-for-the-treatment-of-dementia-associated-with-alzheimer's-disease-or-parkinson's-disease/ 2025-08-28T13:39:19.433Z https://www.ace-hta.gov.sg/healthcare-professionals/ace-technology-guidances/drug-guidance/romosozumab-and-teriparatide-for-treating-osteoporosis/ 2025-08-28T13:39:19.433Z https://www.ace-hta.gov.sg/healthcare-professionals/ace-technology-guidances/drug-guidance/ruxolitinib-for-treating-graft-versus-host-disease/ 2025-08-28T13:39:19.433Z https://www.ace-hta.gov.sg/healthcare-professionals/ace-technology-guidances/drug-guidance/ruxolitinib-for-treating-polycythaemia-vera/ 2025-08-28T13:39:19.433Z https://www.ace-hta.gov.sg/healthcare-professionals/ace-technology-guidances/drug-guidance/sacituzumab-govitecan-for-unresectable-locally-advanced-or-metastatic-hr-positive--her2-negative-breast-cancer/ 2025-09-16T08:03:58.196Z https://www.ace-hta.gov.sg/healthcare-professionals/ace-technology-guidances/drug-guidance/sacubitril-valsartan-for-treating-chronic-heart-failure-with-reduced-ejection-fraction/ 2025-08-28T13:39:19.433Z https://www.ace-hta.gov.sg/healthcare-professionals/ace-technology-guidances/drug-guidance/second-generation-antipsychotic-injections-for-treating-schizophrenia/ 2025-08-28T13:39:19.433Z https://www.ace-hta.gov.sg/healthcare-professionals/ace-technology-guidances/drug-guidance/selexipag--for-treating-pulmonary-arterial-hypertension/ 2025-10-13T03:54:27.698Z https://www.ace-hta.gov.sg/healthcare-professionals/ace-technology-guidances/drug-guidance/sglt2-inhibitors-for-treating-heart-failure-with-reduced-ejection-fraction-and-chronic-kidney-disease/ 2025-08-28T13:39:19.433Z https://www.ace-hta.gov.sg/healthcare-professionals/ace-technology-guidances/drug-guidance/sitagliptin-for-treating-type-2-diabetes-mellitus/ 2025-08-28T13:39:19.433Z https://www.ace-hta.gov.sg/healthcare-professionals/ace-technology-guidances/drug-guidance/sodium-zirconium-cyclosilicate-for-treating-hyperkalaemia/ 2026-02-06T05:41:27.434Z https://www.ace-hta.gov.sg/healthcare-professionals/ace-technology-guidances/drug-guidance/sodium-glucose-co-transporter-2-(sglt2)-inhibitors-for-type-2-diabetes-mellitus/ 2025-08-28T13:39:19.433Z https://www.ace-hta.gov.sg/healthcare-professionals/ace-technology-guidances/drug-guidance/solifenacin-for-treating-overactive-bladder/ 2025-08-28T13:39:19.433Z https://www.ace-hta.gov.sg/healthcare-professionals/ace-technology-guidances/drug-guidance/sotorasib-for-previously-treated-kras-g12c-mutated-locally-advanced-or-metastatic-non-small-cell-lung-cancer/ 2025-09-16T14:21:08.206Z https://www.ace-hta.gov.sg/healthcare-professionals/ace-technology-guidances/drug-guidance/subcutaneous-infliximab-biosimilar--for-treating-inflammatory-conditions/ 2025-08-28T13:39:19.433Z https://www.ace-hta.gov.sg/healthcare-professionals/ace-technology-guidances/drug-guidance/sucroferric-oxyhydroxide-for-treating-hyperphosphataemia-in-patients-with-end-stage-renal-disease-on-dialysis/ 2025-09-16T09:45:57.771Z https://www.ace-hta.gov.sg/healthcare-professionals/ace-technology-guidances/drug-guidance/sumatriptan-for-the-treatment-of-acute-migraine-attacks2/ 2025-08-28T13:39:19.433Z https://www.ace-hta.gov.sg/healthcare-professionals/ace-technology-guidances/drug-guidance/tafamidis-for-treating-transthyretin-amyloid-cardiomyopathy/ 2025-08-28T13:39:19.433Z https://www.ace-hta.gov.sg/healthcare-professionals/ace-technology-guidances/drug-guidance/talazoparib-in-combination-with-enzalutamide-for-treating-hrr-gene-mutated-metastatic-castration-resistant-prostate-cancer/ 2025-09-16T09:40:49.139Z https://www.ace-hta.gov.sg/healthcare-professionals/ace-technology-guidances/drug-guidance/talquetamab-for-relapsed-or-refractory-multiple-myeloma-/ 2026-02-06T07:51:17.224Z https://www.ace-hta.gov.sg/healthcare-professionals/ace-technology-guidances/drug-guidance/temozolomide-for-the-treatment-of-malignant-glioma/ 2025-08-28T13:39:19.433Z https://www.ace-hta.gov.sg/healthcare-professionals/ace-technology-guidances/drug-guidance/tenofovir-alafenamide-for-treating-chronic-hepatitis-b-infection/ 2025-08-28T13:39:19.433Z https://www.ace-hta.gov.sg/healthcare-professionals/ace-technology-guidances/drug-guidance/teriparatide-biosimilar-for-treating-osteoporosis/ 2025-08-28T13:39:19.433Z https://www.ace-hta.gov.sg/healthcare-professionals/ace-technology-guidances/drug-guidance/ticagrelor-for-preventing-thrombotic-events-in-adults-with-acute-coronary-syndromes/ 2025-08-28T13:39:19.433Z https://www.ace-hta.gov.sg/healthcare-professionals/ace-technology-guidances/drug-guidance/tisagenlecleucel-for-relapsed-or-refractory-b-cell-acute-lymphoblastic-leukaemia/ 2025-08-28T13:39:19.433Z https://www.ace-hta.gov.sg/healthcare-professionals/ace-technology-guidances/drug-guidance/tisagenlecleucel-for-relapsed-or-refractory-diffuse-large-b-cell-lymphoma-after-two-or-more-lines-of-systemic-therapy/ 2025-08-28T13:39:19.433Z https://www.ace-hta.gov.sg/healthcare-professionals/ace-technology-guidances/drug-guidance/tislelizumab-for-treating-locally-advanced-or-metastatic-non-squamous-non-small-cell-lung-cancer-without-egfr-or-alk-genomic-tumour-aberrations/ 2026-03-06T05:21:05.578Z https://www.ace-hta.gov.sg/healthcare-professionals/ace-technology-guidances/drug-guidance/tislelizumab-for-treating-non-small-cell-lung-cancer--oesophageal-squamous-cell-carcinoma--and-nasopharyngeal-carcinoma/ 2026-03-06T05:20:43.981Z https://www.ace-hta.gov.sg/healthcare-professionals/ace-technology-guidances/drug-guidance/tofacitinib-ustekinumab-and-vedolizumab-for-treating-inflammatory-bowel-disease/ 2026-02-06T03:54:51.724Z https://www.ace-hta.gov.sg/healthcare-professionals/ace-technology-guidances/drug-guidance/tolvaptan-for-treating-autosomal-dominant-polycystic-kidney-disease/ 2025-08-28T13:39:19.433Z https://www.ace-hta.gov.sg/healthcare-professionals/ace-technology-guidances/drug-guidance/toripalimab-for-first-line-systemic-treatment-of-recurrent-or-metastatic-nasopharyngeal-carcinoma/ 2026-02-06T05:58:37.821Z https://www.ace-hta.gov.sg/healthcare-professionals/ace-technology-guidances/drug-guidance/trastuzumab-deruxtecan-for-her2-low-unresectable-and-or-metastatic-breast-cancer-after-at-least-one-prior-line-of-chemotherapy/ 2025-08-28T13:39:19.433Z https://www.ace-hta.gov.sg/healthcare-professionals/ace-technology-guidances/drug-guidance/trastuzumab-deruxtecan-for-previously-treated-her2-positive-metastatic-breast-cancer/ 2025-08-28T13:39:19.433Z https://www.ace-hta.gov.sg/healthcare-professionals/ace-technology-guidances/drug-guidance/trastuzumab-deruxtecan-for-treating-her2-positive-advanced-gastric-cancer-after-two-or-more-therapies/ 2025-08-28T13:39:19.433Z https://www.ace-hta.gov.sg/healthcare-professionals/ace-technology-guidances/drug-guidance/trastuzumab-deruxtecan-for-unresectable-or-metastatic-her2-positive-solid-tumours-after-at-least-one-prior-line-of-systemic-therapy/ 2026-02-06T08:26:49.914Z https://www.ace-hta.gov.sg/healthcare-professionals/ace-technology-guidances/drug-guidance/trastuzumab-deruxtecan-for-unresectable-or-metastatic-non-small-cell-lung-cancer-whose-tumours-have-activating-her2--erbb2--mutations-and-who-have-received-a-prior-systemic-therapy/ 2026-02-06T08:33:16.911Z https://www.ace-hta.gov.sg/healthcare-professionals/ace-technology-guidances/drug-guidance/triple-therapy-inhalers-for-treating-asthma-or-chronic-obstructive-pulmonary-disease/ 2025-08-28T13:39:19.433Z https://www.ace-hta.gov.sg/healthcare-professionals/ace-technology-guidances/drug-guidance/tyrosine-kinase-inhibitors-for-renal-cell-carcinoma--rcc-/ 2025-03-20T13:24:14.271Z https://www.ace-hta.gov.sg/healthcare-professionals/ace-technology-guidances/drug-guidance/tyrosine-kinase-inhibitors-for-treating-alk-mutation-positive-advanced-non-small-cell-lung-cancer/ 2025-08-28T13:39:19.433Z https://www.ace-hta.gov.sg/healthcare-professionals/ace-technology-guidances/drug-guidance/tyrosine-kinase-inhibitors-for-treating-met-mutation-positive-metastatic-non-small-cell-lung-cancer/ 2025-08-28T13:39:19.433Z https://www.ace-hta.gov.sg/healthcare-professionals/ace-technology-guidances/drug-guidance/tyrosine-kinase-inhibitors-immune-checkpoint-inhibitors-and-everolimus-for-treating-advanced-renal-cell-cancer/ 2025-08-28T13:39:19.433Z https://www.ace-hta.gov.sg/healthcare-professionals/ace-technology-guidances/drug-guidance/update-of-moh-list-of-subsidised-drugs-to-include-treatments-for-various-cancer-conditions/ 2026-04-01T00:48:21.718Z https://www.ace-hta.gov.sg/healthcare-professionals/ace-technology-guidances/drug-guidance/ursodeoxycholic-acid-for-treating-primary-biliary-cirrhosis/ 2025-08-28T13:39:19.433Z https://www.ace-hta.gov.sg/healthcare-professionals/ace-technology-guidances/drug-guidance/ustekinumab-biosimilar-for-treating-inflammatory-conditions/ 2026-03-06T05:18:19.232Z https://www.ace-hta.gov.sg/healthcare-professionals/ace-technology-guidances/drug-guidance/ustekinumab-for-the-treatment-of-chronic-plaque-psoriasis-and-psoriatic-arthritis/ 2026-02-06T05:16:16.941Z https://www.ace-hta.gov.sg/healthcare-professionals/ace-technology-guidances/drug-guidance/vonoprazan-for-treating-helicobacter-pylori-infection/ 2025-08-28T13:39:19.433Z https://www.ace-hta.gov.sg/healthcare-professionals/ace-technology-guidances/drug-guidance/vortioxetine-for-treatment-of-depression/ 2025-08-28T13:39:19.433Z https://www.ace-hta.gov.sg/healthcare-professionals/ace-technology-guidances/drug-guidance/zolbetuximab-for-untreated-her2-negative--claudin-18-2-positive--unresectable-advanced-gastric-or-gastroesophageal-junction-adenocarcinoma-/ 2026-02-08T00:53:47.010Z https://www.ace-hta.gov.sg/healthcare-professionals/ace-technology-guidances/medical-technology-guidance/ 2025-04-10T09:26:25.904Z https://www.ace-hta.gov.sg/healthcare-professionals/ace-technology-guidances/medical-technology-guidance/-advanced-hybrid-closed-loop-system---for-people-with-type-1-diabetes-mellitus-/ 2025-10-22T06:47:56.461Z https://www.ace-hta.gov.sg/healthcare-professionals/ace-technology-guidances/medical-technology-guidance/18f-fluorodeoxyglucose-positron-emission-tomography-with-computed-tomography-(fdg-pet-ct)-for-oncological-indications/ 2025-03-20T11:30:46.213Z https://www.ace-hta.gov.sg/healthcare-professionals/ace-technology-guidances/medical-technology-guidance/active-middle-ear-implants-for-patients-with-hearing-loss/ 2025-03-20T11:30:46.321Z https://www.ace-hta.gov.sg/healthcare-professionals/ace-technology-guidances/medical-technology-guidance/acupuncture-for-adults-with-low-back-pain-and-neck-pain/ 2025-03-20T11:30:46.358Z https://www.ace-hta.gov.sg/healthcare-professionals/ace-technology-guidances/medical-technology-guidance/antibacterial-envelope-for-implantable-neurostimulator-infection-control/ 2025-04-09T02:05:01.077Z https://www.ace-hta.gov.sg/healthcare-professionals/ace-technology-guidances/medical-technology-guidance/antibacterial-envelope-for-the-prevention-of-cardiac-implantable-electronic-device-related-infections/ 2025-03-20T11:30:46.465Z https://www.ace-hta.gov.sg/healthcare-professionals/ace-technology-guidances/medical-technology-guidance/aortic-hybrid-stent-graft-for-treating-complex-aortic-disease/ 2025-03-20T11:30:46.551Z https://www.ace-hta.gov.sg/healthcare-professionals/ace-technology-guidances/medical-technology-guidance/bilateral-cochlear-implants-for-children-with-severe-to-profound-sensorineural-hearing-loss-in-both-ears/ 2025-03-20T11:30:46.600Z https://www.ace-hta.gov.sg/healthcare-professionals/ace-technology-guidances/medical-technology-guidance/bone-conduction-hearing-implants-for-patients-with-conductive-or-mixed-hearing-loss/ 2025-03-20T11:30:46.677Z https://www.ace-hta.gov.sg/healthcare-professionals/ace-technology-guidances/medical-technology-guidance/bone-conduction-hearing-implants-for-patients-with-single-sided-deafness/ 2025-03-20T11:30:46.756Z https://www.ace-hta.gov.sg/healthcare-professionals/ace-technology-guidances/medical-technology-guidance/cervical-artificial-disc-replacement-for-treatment-of-patients-with-cervical-disc-degenerative-disease/ 2025-03-20T11:30:46.792Z https://www.ace-hta.gov.sg/healthcare-professionals/ace-technology-guidances/medical-technology-guidance/cochlear-implants-for-children-with-single-sided-deafness/ 2025-03-20T11:30:46.850Z https://www.ace-hta.gov.sg/healthcare-professionals/ace-technology-guidances/medical-technology-guidance/cochlear-implants-for-treating-adults-with-single-sided-deafness-(ssd)/ 2025-03-20T11:30:46.908Z https://www.ace-hta.gov.sg/healthcare-professionals/ace-technology-guidances/medical-technology-guidance/continuous-glucose-monitoring-systems-for-children-and-adults-with-type-1-diabetes-mellitus/ 2025-12-01T01:19:00.656Z https://www.ace-hta.gov.sg/healthcare-professionals/ace-technology-guidances/medical-technology-guidance/insulin-pumps-for-people-with-type-1-diabetes/ 2025-03-20T11:30:47.126Z https://www.ace-hta.gov.sg/healthcare-professionals/ace-technology-guidances/medical-technology-guidance/coronary-intravascular-lithotripsy-for-patients-with-severely-calcified-stenotic-de-novo-coronary-artery/ 2025-03-20T11:30:47.024Z https://www.ace-hta.gov.sg/healthcare-professionals/ace-technology-guidances/medical-technology-guidance/deep-brain-stimulators-for-treatment-of-parkinson-disease--dystonia-or-essential-tremor/ 2025-04-09T01:53:25.835Z https://www.ace-hta.gov.sg/healthcare-professionals/ace-technology-guidances/medical-technology-guidance/elastomeric-infusion-pumps-for-outpatient-parenteral-antimicrobial-therapy/ 2025-04-09T02:07:21.450Z https://www.ace-hta.gov.sg/healthcare-professionals/ace-technology-guidances/medical-technology-guidance/home-sleep-test-for-diagnosing-obstructive-sleep-apnoea/ 2025-04-11T03:51:35.802Z https://www.ace-hta.gov.sg/healthcare-professionals/ace-technology-guidances/medical-technology-guidance/spaceoar-systems-for-rectum-protection-during-prostate-cancer-treatment/ 2025-11-28T01:05:01.990Z https://www.ace-hta.gov.sg/healthcare-professionals/ace-technology-guidances/medical-technology-guidance/intraoperative-cell-salvage/ 2025-09-01T01:21:19.859Z https://www.ace-hta.gov.sg/healthcare-professionals/ace-technology-guidances/medical-technology-guidance/lumbar-artificial-disc-replacement-for-treatment-of-patients-with-lumbar-disc-degenerative-disease/ 2025-03-20T11:30:47.163Z https://www.ace-hta.gov.sg/healthcare-professionals/ace-technology-guidances/medical-technology-guidance/magnetic-resonance-image-guided-radiation-therapy-for-patients-with-cancer/ 2025-03-20T11:30:47.240Z https://www.ace-hta.gov.sg/healthcare-professionals/ace-technology-guidances/medical-technology-guidance/minimally-invasive-glaucoma-surgery-(migs)-implants-for-treating-patients-with-mild-to-moderate-primary-open-angle-glaucoma-(poag)/ 2025-03-20T11:30:47.300Z https://www.ace-hta.gov.sg/healthcare-professionals/ace-technology-guidances/medical-technology-guidance/mri-us-fusion-targeted-biopsy-for-diagnosis-of-prostate-cancer/ 2025-03-20T11:30:47.374Z https://www.ace-hta.gov.sg/healthcare-professionals/ace-technology-guidances/medical-technology-guidance/negative-pressure-wound-therapy-for-wound-management-in-patients-with-diabetes-(type-1-and-2)/ 2025-03-20T11:30:47.425Z https://www.ace-hta.gov.sg/healthcare-professionals/ace-technology-guidances/medical-technology-guidance/percutaneous-vertebral-augmentation-systems-for-treating-patients-with-vertebral-compression-fractures/ 2025-03-20T11:30:47.487Z https://www.ace-hta.gov.sg/healthcare-professionals/ace-technology-guidances/medical-technology-guidance/photodynamic-therapy-for-treating-non-melanoma-skin-tumours/ 2025-03-20T11:30:47.572Z https://www.ace-hta.gov.sg/healthcare-professionals/ace-technology-guidances/medical-technology-guidance/positive-airway-pressure-for-moderate-to-severe-obstructive-sleep-apnoea/ 2026-04-01T01:00:22.503Z https://www.ace-hta.gov.sg/healthcare-professionals/ace-technology-guidances/medical-technology-guidance/presbyopia-correcting-intraocular-lenses-for-treating-patients-with-cataract/ 2025-03-20T11:30:47.605Z https://www.ace-hta.gov.sg/healthcare-professionals/ace-technology-guidances/medical-technology-guidance/radiolucent-fixation-rods---screws-for-patients-with-primary-and-metastatic-spinal-tumours/ 2025-03-20T11:30:47.664Z https://www.ace-hta.gov.sg/healthcare-professionals/ace-technology-guidances/medical-technology-guidance/repetitive-transcranial-magnetic-stimulation-for-adults-with-treatment-resistant-major-depressive-disorder/ 2025-03-20T11:30:47.727Z https://www.ace-hta.gov.sg/healthcare-professionals/ace-technology-guidances/medical-technology-guidance/robot-assisted-endovascular-intervention-systems-for-coronary-artery-disease-and-other-vascular-diseases/ 2025-03-20T11:30:47.778Z https://www.ace-hta.gov.sg/healthcare-professionals/ace-technology-guidances/medical-technology-guidance/sirolimus-coated-percutaneous-transluminal-coronary-angioplasty-balloon-catheters-(scbs)-for-patients-with-coronary-artery-disease-(cad)/ 2025-11-05T15:20:26.385Z https://www.ace-hta.gov.sg/healthcare-professionals/ace-technology-guidances/medical-technology-guidance/thoracic-and-abdominal-endovascular-repair-(t-evar)-for-the-structural-support-of-aortic-aneurysm/ 2025-03-20T11:30:47.961Z https://www.ace-hta.gov.sg/healthcare-professionals/ace-technology-guidances/medical-technology-guidance/transcatheter-aortic-valve-implantation--tavi--for-patients-with-symptomatic-severe-native-aortic-stenosis/ 2026-03-27T01:37:16.381Z https://www.ace-hta.gov.sg/healthcare-professionals/ace-technology-guidances/medical-technology-guidance/transcatheter-mitral-valve-leaflet-repair-(tmvlr)-for-patients-with-mitral-regurgitation/ 2025-03-20T11:30:48.087Z https://www.ace-hta.gov.sg/healthcare-professionals/ace-technology-guidances/medical-technology-guidance/tricuspid-transcatheter-edge-to-edge-repair-system-for-symptomatic-severe-tricuspid-regurgitation/ 2025-03-20T11:30:48.122Z https://www.ace-hta.gov.sg/healthcare-professionals/ace-technology-guidances/medical-technology-guidance/video-capsule-endoscopy-for-diagnosing-obscure-gastrointestinal-bleeding/ 2025-03-20T11:30:48.182Z https://www.ace-hta.gov.sg/healthcare-professionals/ace-technology-guidances/medical-technology-guidance/wingspan-stent-system-for-intracranial-atherosclerotic-stenosis/ 2025-03-20T11:30:48.216Z https://www.ace-hta.gov.sg/news/ 2026-04-02T07:18:49.600Z https://www.ace-hta.gov.sg/news/announcements/ 2025-04-10T09:26:36.809Z https://www.ace-hta.gov.sg/news/announcements/ace-clinical-update-service-cues-now-available/ 2025-03-20T11:30:48.607Z https://www.ace-hta.gov.sg/news/announcements/annual-call-for-drug-funding-applications-now-open---2026/ 2025-10-01T09:11:12.445Z https://www.ace-hta.gov.sg/news/announcements/company-led-submission-pilot-for-early-evaluation-of-non-cancer-drugs/ 2025-03-20T11:30:50.203Z https://www.ace-hta.gov.sg/news/events/ 2025-04-10T09:26:49.419Z https://www.ace-hta.gov.sg/news/events/12th-htasialink-conference-2025/ 2025-11-11T03:43:43.717Z https://www.ace-hta.gov.sg/news/events/ace-clinical-guideline--acg--topic-call-2025/ 2025-12-17T08:53:32.475Z https://www.ace-hta.gov.sg/news/events/ace-seminar-approach-to-assessing-and-managing-headache-as-the-presenting-symptom/ 2025-03-20T11:30:58.725Z https://www.ace-hta.gov.sg/news/events/ace-value-based-healthcare-conference-2024/ 2025-12-09T03:41:54.699Z https://www.ace-hta.gov.sg/news/events/ace-webinar-let-s-talk-about-asthma-making-asthma-patient-education-meaningful/ 2025-03-20T11:30:58.840Z https://www.ace-hta.gov.sg/news/events/ace-webinar-managing-pre-diabetes-beyond-guidelines-for-better-outcomes/ 2025-03-20T11:30:58.876Z https://www.ace-hta.gov.sg/news/events/ace-webinar-when-to-order-mri-for-low-back-pain/ 2025-03-20T11:30:58.948Z https://www.ace-hta.gov.sg/news/events/annual-call-for-acg-topic-submissions-2024/ 2025-03-20T11:30:59.022Z https://www.ace-hta.gov.sg/news/events/annual-call-for-applications-medical-technology-evaluation-for-subsidy-consideration-2024/ 2025-03-20T11:30:59.078Z https://www.ace-hta.gov.sg/news/events/annual-call-for-applications-medical-technology-evaluation-for-subsidy-consideration-2025/ 2025-03-20T11:30:59.168Z https://www.ace-hta.gov.sg/news/events/annual-call-for-drug-applications-to-be-submitted-for-funding-consideration-2024/ 2025-03-20T11:30:59.276Z https://www.ace-hta.gov.sg/news/events/annual-call-for-drug-applications-to-be-submitted-for-funding-consideration-2023/ 2025-03-20T11:30:59.204Z https://www.ace-hta.gov.sg/news/events/annual-call-for-drug-applications-to-be-submitted-for-funding-consideration-2025/ 2025-03-20T11:30:59.311Z https://www.ace-hta.gov.sg/news/events/annual-call-for-medical-technology-applications-to-be-submitted-for-subsidy-consideration-2023/ 2025-03-20T11:30:59.373Z https://www.ace-hta.gov.sg/news/events/annual-industry-notification-exercise-for-pipeline-medical-technologies-2024/ 2025-03-20T11:30:59.452Z https://www.ace-hta.gov.sg/news/events/avbc-conference-2025/ 2026-03-24T07:13:37.226Z https://www.ace-hta.gov.sg/news/events/good-practice-update-pre-diabetes-and-oral-glucose-lowering-agents/ 2025-03-20T11:30:59.551Z https://www.ace-hta.gov.sg/news/events/managing-asthma-what-every-primary-care-clinician-needs-to-know/ 2025-03-20T11:30:59.667Z https://www.ace-hta.gov.sg/news/events/value-based-healthcare-conference-2022/ 2025-03-20T11:30:59.754Z https://www.ace-hta.gov.sg/news/newsletter/ 2026-01-15T08:26:39.726Z https://www.ace-hta.gov.sg/news/vbhc-highlights/ 2025-10-21T08:23:41.015Z https://www.ace-hta.gov.sg/patients-and-community/ 2025-09-04T08:37:50.571Z https://www.ace-hta.gov.sg/patients-and-community/cee-updates/ 2025-12-16T04:23:45.690Z https://www.ace-hta.gov.sg/patients-and-community/educational-resources/ 2025-04-10T09:26:59.362Z https://www.ace-hta.gov.sg/patients-and-community/learning-modules-for-patients-and-the-public/ 2025-05-26T09:23:30.140Z https://www.ace-hta.gov.sg/patients-and-community/opportunities-for-patient-involvement/ 2025-04-10T09:27:07.668Z https://www.ace-hta.gov.sg/patients-and-community/opportunities-for-patient-involvement/co-creating-meaningful-patient-engagement/ 2025-05-28T07:35:19.800Z https://www.ace-hta.gov.sg/patients-and-community/opportunities-for-patient-involvement/patients-as-essential-partners-in-healthcare/ 2025-05-28T07:42:46.166Z https://www.ace-hta.gov.sg/patients-and-community/opportunities-for-patient-involvement/transforming-patient-engagement-in-singapore/ 2025-05-30T04:38:13.911Z https://www.ace-hta.gov.sg/vhbc-images/ 2025-03-20T11:31:07.891Z https://www.ace-hta.gov.sg/privacy/ 2025-03-20T11:31:07.666Z https://www.ace-hta.gov.sg/resources/ 2026-04-02T07:18:49.600Z https://www.ace-hta.gov.sg/resources/arcg-register/ 2026-03-31T04:32:57.510Z https://www.ace-hta.gov.sg/resources/archives/ 2026-04-02T07:18:49.697Z https://www.ace-hta.gov.sg/resources/archives/covid-19-resources/ 2025-03-20T11:31:03.254Z https://www.ace-hta.gov.sg/resources/g4g-resources/ 2026-03-31T01:55:54.767Z https://www.ace-hta.gov.sg/resources/guidelines-for-guidelines/ 2026-01-29T08:04:36.131Z https://www.ace-hta.gov.sg/resources/process-methods/ 2026-03-20T03:58:25.480Z https://www.ace-hta.gov.sg/resources/scientific-publications/ 2025-11-10T14:30:28.610Z https://www.ace-hta.gov.sg/resources/video-resources/ 2025-11-10T08:35:26.685Z https://www.ace-hta.gov.sg/search/ 2025-03-20T11:31:07.722Z https://www.ace-hta.gov.sg/terms-of-use/ 2025-03-20T11:31:07.817Z